We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

71 hedge funds and large institutions have $120M invested in VanEck Biotech ETF in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 30 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $6.29M | Put options by funds: $3.83M

1.88% less ownership

Funds ownership: 24.14% → 22.25% (-1.9%)

21% less funds holding

Funds holding: 90 → 71 (-19)

28% less capital invested

Capital invested by funds: $167M → $120M (-$47.4M)

43% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 30

68% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 25

Holders
71
Holders Change
-19
Holders Change %
-21.11%
% of All Funds
1.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
17
Reduced
30
Closed
25
Calls
$6.29M
Puts
$3.83M
Net Calls
+$2.46M
Net Calls Change
+$2.55M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$4.42M
2
VF
Virtu Financial
New York
+$2.81M
3
AL
Aspiriant LLC
California
+$2.66M
4
SG Americas Securities
SG Americas Securities
New York
+$2.25M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$980K

Top Sellers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
-$8.85M
2
LTFS
Ladenburg Thalmann Financial Services
Florida
-$2.19M
3
UBS Group
UBS Group
Switzerland
-$1.69M
4
Wells Fargo
Wells Fargo
California
-$1.44M
5
BPC
Banque Pictet & Cie
Switzerland
-$1.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
WJA
26
Williams Jones & Associates
New York
$764K -$285K -2,735 -27%
MFS
27
MSI Financial Services
Massachusetts
$732K -$762K -7,304 -51%
HSBC Holdings
28
HSBC Holdings
United Kingdom
$728K +$82.9K +795 +13%
VKH
29
Virtu KCG Holdings
New York
$721K -$508K -4,874 -41%
LTFS
30
Ladenburg Thalmann Financial Services
Florida
$691K -$2.19M -21,014 -76%
GJIC
31
Gamble Jones Investment Counsel
California
$622K – – –
HF
32
HRT Financial
New York
$597K +$362K +3,467 +151%
TH
33
Timber Hill
Connecticut
$561K +$322K +3,086 +133%
Wells Fargo
34
Wells Fargo
California
$523K -$1.44M -13,773 -73%
RJA
35
Raymond James & Associates
Florida
$494K +$497K +4,764 New
EDRH
36
Edmond de Rothschild Holding
Switzerland
$459K -$1.12M -10,775 -71%
IA
37
IFP Advisors
Florida
$428K -$473K -4,536 -58%
IAMOG
38
Investors Asset Management of Georgia
Georgia
$384K – – –
CCT
39
Country Club Trust
Missouri
$319K +$16.2K +155 +5%
AB
40
Atlas Brown
Kentucky
$314K -$1.25K -12 -0.4%
First Manhattan
41
First Manhattan
New York
$311K – – –
Bank of New York Mellon
42
Bank of New York Mellon
New York
$311K +$146K +1,401 +88%
SC
43
Scotia Capital
Ontario, Canada
$302K +$66.7K +640 +28%
Cambridge Investment Research Advisors
44
Cambridge Investment Research Advisors
Iowa
$295K -$36.5K -350 -11%
FAAS
45
First Allied Advisory Services
California
$293K – – –
PCMM
46
Private Capital Management (Minnesota)
Minnesota
$290K +$162K +1,550 +124%
RJFSA
47
Raymond James Financial Services Advisors
Florida
$272K +$273K +2,619 New
AIG
48
American International Group
New York
$242K -$375K -3,594 -61%
BRWA
49
B. Riley Wealth Advisors
Florida
$235K +$28.9K +277 +14%
TRCT
50
Tower Research Capital (TRC)
New York
$227K -$488K -4,678 -68%
1
2
3 4

BBH Hedge Fund Activity: Q1 2016 in Review

71 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2016, worth a combined $120M — down 28% from $167M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of BBH and 8 opened new positions — a net loss of 17 holders — while 30 trimmed existing stakes and 17 added.

The largest buyer was Morgan Stanley, adding an estimated $4.42M. The largest seller was Credit Suisse, exiting entirely with an estimated $8.85M sold.

  • 71 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2016, down from 90 in Q4 2015.
  • Funds reported $120M of VanEck Biotech ETF stock for Q1 2016, down 28% quarter-over-quarter.
  • 8 funds opened new VanEck Biotech ETF positions in Q1 2016 and 25 closed out, a net change of -17 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2016 was Morgan Stanley, an estimated $4.42M added.
  • The largest VanEck Biotech ETF seller in Q1 2016 was Credit Suisse, an estimated $8.85M sold.

Based on aggregated 13F filings for Q1 2016.